India’s diagnostics market is undergoing a quiet but profound shift as at-home testing, e-pharmacies and quick commerce collide on the patient’s smartphone screen. From Zepto’s partnership with Orange Health Labs to Apollo 24/7’s omnichannel diagnostics network and PharmEasy’s Thyrocare-powered home collection, the lab now comes to the consumer instead of the other way around. This convergence is reshaping competitive dynamics for pharma companies, payers and health systems that depend on diagnostics as the front door to care.[1][2][3][4][5]
India’s at-home diagnostics moment
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
